Bio-Techne
TECH
#2283
Rank
C$11.46 B
Marketcap
C$73.21
Share price
-3.51%
Change (1 day)
4.38%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): C$0.99

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is C$0.99. In 2025 the company made an earnings per share (EPS) of C$0.73 a decrease over its 2024 EPS that were of C$1.39.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$0.9935.97%
2025C$0.73-48%
2024C$1.39-29.58%
2023C$1.98-14.97%
2022C$2.3324.16%
2021C$1.8817.98%
2020C$1.59-10.94%
2019C$1.78101.57%
2018C$0.89-16.99%
2017C$1.0745.02%
2016C$0.74-20.97%
2015C$0.93-14.97%
2014C$1.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$25.41 2,466.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$7.61 669.01%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$11.42 1,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
C$7.24 630.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
C$2.87 190.15%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
C-$0.29-129.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C$8.52 760.56%๐Ÿ‡บ๐Ÿ‡ธ USA